Brief: Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million
06/08/2026 12:01
BRIEF-Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million Aug 06 (Reuters) - Evolent Health Q2 adjusted EBITDA USD 28.05 million.
- Q2 adjusted EBITDA margin 4.3%
- Q2 net income USD -28.364 million
- outlook FY adjusted EBITDA USD 120-135 million
Recent news on Evolent Health
See all newsEvolent Health, Inc. reports results for the quarter ended June 30 - Earnings Summary
Evolent Health Q2 revenue beats expectations
Brief: Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million
Evolent Health, Inc. expected to post a loss of 2 cents a share - Earnings Preview
Evolent Health Q1 revenue misses estimates as margin narrows